Oncternal Therapeutics Announces Presentation of Case Study of TK216 in Ewing Sarcoma Given at the Children?s Oncology Group Meeting

Oncternal Therapeutics Announces Presentation of Case Study of TK216 in Ewing Sarcoma Given at the Children?s Oncology Group Meeting

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 /

RSS Feed

Share

Link

Embed

SAN DIEGO–(BUSINESS WIRE)–Oncternal Therapeutics Announces Presentation of Case Study of TK216 in Ewing Sarcoma. Given at the Children?s Oncology Group Meeting